Reporting owner · CIK 0001643653

Benevich Eric

Visual SEC Form 4 history across 1 companies, 20 transactions and 5 filings.

CCOChief Commercial OfficerNEUROCRINE BIOSCIENCES INC
Open-market mix
Latest filingSep 11, 2026, 12:29 AM
Filings5Form 4 records
Buying$00 purchases
Selling$885K5 sales
Net value−$885KBuys minus sells
Companies14 securities
Most recentSep 09, 2026exercise

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-51Jan 253Feb 25Jan 261Sep 26

Net value flow

Buys minus sells

Jan 25
−$184.6K
Feb 25
−$367.4K
Jan 26
$0
Sep 26
−$333K

Transaction texture

Ownership and ticket size

Average P/S size$177K
Median P/S size$128.2K
Direct20
Indirect0
Sep 09, 2026exercise

Filing-only signals

Deterministic matches in this insider's history

Cluster Sellingpattern4Derivative Transactionfiling-context7Direct Ownershipfiling-context17Large Holdings Increaseholdings2Large Holdings Reductionholdings3Repeat Sellerpattern310b5-1 Detectedfiling-context14

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at NEUROCRINE BIOSCIENCES INC on Sep 09, 2026 valued at $333,030.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at NEUROCRINE BIOSCIENCES INC on Sep 09, 2026 valued at $333,030.

Review SEC filing

Associated companies

Visual map of known reporting history

NBIXNEUROCRINE BIOSCIENCES INC20 transactions · latest Sep 11, 2026, 12:29 AM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
NBIXBENEVICH ERIC
CCO
sale10b5-11.05k-$12.3MS
Cluster Selling Direct Ownership Repeat Seller+1
—02/14/202502/13/2025
NBIXBENEVICH ERIC
CCO
exercise10b5-11.96k$0M
Direct Ownership 10b5-1 Detected
—02/14/202502/13/2025
NBIXBENEVICH ERIC
CCO
sale10b5-11.09k-$12.8MS
Cluster Selling Direct Ownership Repeat Seller+1
—02/14/202502/13/2025
NBIXBENEVICH ERIC
CCO
exercise10b5-12.08k$0M
Direct Ownership 10b5-1 Detected
—02/14/202502/13/2025
NBIXBENEVICH ERIC
CCO
exercise10b5-11.86k$0M
Derivative Transaction Direct Ownership 10b5-1 Detected
—02/12/202502/08/2025
NBIXBENEVICH ERIC
CCO
sale10b5-1980-$11.5MS
Cluster Selling Direct Ownership Repeat Seller+1
—02/12/202502/10/2025
NBIXBENEVICH ERIC
CCO
exercise10b5-11.86k$0M
Direct Ownership 10b5-1 Detected
—02/12/202502/08/2025
NBIXBENEVICH ERIC
CCO
exercise10b5-12.29k$0M
Derivative Transaction Direct Ownership Large Holdings Reduction+1
—02/04/202501/31/2025
NBIXBENEVICH ERIC
CCO
sale10b5-11.20k-$18.4MS
Cluster Selling Direct Ownership 10b5-1 Detected
—02/04/202501/31/2025
NBIXBENEVICH ERIC
CCO
exercise10b5-12.29k$0M
Direct Ownership 10b5-1 Detected
—02/04/202501/31/2025

Benevich Eric Insider Activity FAQ

SEC Form 4 context

Who is Benevich Eric?

Benevich Eric is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001643653.

Which companies has Benevich Eric reported transactions for?

NEUROCRINE BIOSCIENCES INC

When was Benevich Eric's latest insider buy?

No open-market insider purchase is available for this period.

When was Benevich Eric's latest insider sale?

sale at NEUROCRINE BIOSCIENCES INC on Sep 09, 2026 valued at $333,030.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.